<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/62A9A55D-8318-4DBA-9F54-1563897BAA9B"><gtr:id>62A9A55D-8318-4DBA-9F54-1563897BAA9B</gtr:id><gtr:name>Bruker Corporation</gtr:name><gtr:address><gtr:line1>19 Fortune Drive</gtr:line1><gtr:line2>Manning Park</gtr:line2><gtr:postCode>01821</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/AD778175-520B-4F9C-9D6A-68762F7D71A2"><gtr:id>AD778175-520B-4F9C-9D6A-68762F7D71A2</gtr:id><gtr:firstName>Kira</gtr:firstName><gtr:surname>Weissman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6E503EE3-DC5F-4377-B3F7-42499D93F87C"><gtr:id>6E503EE3-DC5F-4377-B3F7-42499D93F87C</gtr:id><gtr:firstName>Jean Olwen</gtr:firstName><gtr:surname>Thomas</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/238CDD3E-D012-4C06-B3B4-9B4C8C1F5A8E"><gtr:id>238CDD3E-D012-4C06-B3B4-9B4C8C1F5A8E</gtr:id><gtr:firstName>Natalia</gtr:firstName><gtr:surname>Murzina</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BEE4BB21-9318-4C65-B651-CEFAB22BCC75"><gtr:id>BEE4BB21-9318-4C65-B651-CEFAB22BCC75</gtr:id><gtr:firstName>Luca</gtr:firstName><gtr:surname>Pellegrini</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EFBAD219-504A-49BA-9A3A-660ACD27F789"><gtr:id>EFBAD219-504A-49BA-9A3A-660ACD27F789</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Leadlay</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DAA8E825-960A-41A0-A69A-A4FBB267907B"><gtr:id>DAA8E825-960A-41A0-A69A-A4FBB267907B</gtr:id><gtr:firstName>Ernest</gtr:firstName><gtr:otherNames>Douglas</gtr:otherNames><gtr:surname>Laue</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/093BE202-310C-452E-8306-CE3141D54ED5"><gtr:id>093BE202-310C-452E-8306-CE3141D54ED5</gtr:id><gtr:firstName>Richard William</gtr:firstName><gtr:surname>Broadhurst</gtr:surname><gtr:orcidId>0000-0002-0264-4593</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BEA4828F-8928-4218-A03B-20230708518C"><gtr:id>BEA4828F-8928-4218-A03B-20230708518C</gtr:id><gtr:firstName>Darerca</gtr:firstName><gtr:surname>Owen</gtr:surname><gtr:orcidId>0000-0003-0978-5425</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AA85AE6A-D3AA-426F-A3E8-06C8403421A4"><gtr:id>AA85AE6A-D3AA-426F-A3E8-06C8403421A4</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Farndale</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CFF64BDA-A3FE-438F-AEC9-631BCB777597"><gtr:id>CFF64BDA-A3FE-438F-AEC9-631BCB777597</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:surname>Nietlispach</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D099FFE8-DF94-462F-8B16-B943AA467BFC"><gtr:id>D099FFE8-DF94-462F-8B16-B943AA467BFC</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Dobson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FA5FFBAD-E500-45BD-8625-88E0E0F77A72"><gtr:id>FA5FFBAD-E500-45BD-8625-88E0E0F77A72</gtr:id><gtr:firstName>Sophie</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Jackson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9C732B3-337A-4410-86A9-C9A45AA70DE6"><gtr:id>C9C732B3-337A-4410-86A9-C9A45AA70DE6</gtr:id><gtr:firstName>Helen</gtr:firstName><gtr:surname>Mott</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/164652CE-CF1C-4153-8C96-B52B5C6C9E77"><gtr:id>164652CE-CF1C-4153-8C96-B52B5C6C9E77</gtr:id><gtr:firstName>David Mark</gtr:firstName><gtr:surname>Carrington</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FE013228%2F1"><gtr:id>C293BEAF-99B4-4C4C-AE20-E02630938838</gtr:id><gtr:title>High Sensitivity Cryoprobe Equipment for the NMR Facility of the Department of Biochemistry University of Cambridge</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/E013228/1</gtr:grantReference><gtr:abstractText>NMR spectroscopy has emerged as a powerful tool to study the structure and mobility of biomacromolecules such as proteins and nucleic acids in their natural environment in solution. A particularly powerful feature of NMR is that interactions of molecules can be studied at an atomic level that allows to differentiate e.g. functional from structural regions in a protein and permit to characterize which residues are involved in a interaction at molecular level. Strengths and timescales of such interactions can be determined which reveal information about the underlying physical mechanisms behind such interactions. Unfortunately, NMR spectroscopy is a relatively insensitive method so that the majority of currently available studies have been limited to smaller proteins &amp;lt; 20 kDa. More recently novel techniques and improved spectrometer hardware have led to a dramatic increase in the basic sensitivity so that the study of larger biomacromolecules has become possible. One such significant advance has been the introduction of the so-called cryoprobe that improves the sensitivity of NMR experiments between two and five-fold. This dramatically higher sensitivity can be used to good advantage, to study larger proteins and their complexes with other proteins or DNA/RNA typically not accessible with conventional equipment, to investigate less abundant or aggregating proteins, or to reduce the time required to perform a particular NMR experiment, thus increasing the capacity of the spectrometer. Our Departmental NMR facility forms a collaborative research environment that serves a wide range of users from the Departments of Biochemistry and Chemistry that work on a multitude of structural projects. Many of these projects involve work with large proteins, or multi-protein complexes or have to be conducted at low protein concentrations so that this work would dramatically benefit from the availability of such cryoprobe equipment. In this application we are requesting funds to install cryoprobes on two out of our four facility machines to be able to pursue our proposed research projects. Some of our outlined projects are extremely demanding and high sensitivity NMR equipment is a pre-requisite for their feasibility. Here are some selected examples of biological and clinical importance from our research plan. Our areas of work cover structural studies of molecules and complexes involved in many aspects of cell-signalling and their implications in cell motility and cancer and the study of cancer susceptibility syndrome proteins involved e.g. in Fanconi Anaemia, a disease that leads to progressive bone marrow failure. Further projects study different aspects of misfolding of proteins such as can be found in plaque in brain tissue of patients that have the debilitating diseases of Alzheimer's or Parkinson's. The study of chromatin, central to the control of gene expression, it's interactions with DNA and many proteins is another major significant research area. Structural studies on intact ribosomes, the cellular centers where protein synthesis occurs, are relatively new and particularly challenging to perform due to the very low concentrations and limited lifetimes of the synthesized nascent protein attached to the ribosome. As a final example we mention the structural study of membrane proteins. These proteins account for ca. 30% of all encoded proteins and control a vast range of biological functions such as respiration, signalling and transport at a molecular level. As they are water insoluble structural information is hardly available. NMR can study such proteins in a detergent solubilized form but the large size of such complexes requires the highest NMR sensitivity available.</gtr:abstractText><gtr:technicalSummary>The aim of this application is to equip the NMR research facility of the Department of Biochemistry with a complete high sensitivity cryoprobe for the 800 MHz NMR spectrometer and to obtain a cryoplatform for an already purchased 500 MHz cryoprobe. Low sensitivity is one of the major limiting factors of NMR spectroscopy in the structural study of biomolecules. Modern cryoprobes increase the sensitivity of conventional equipment by a factor of two to five-fold (depending on salt concentration). The sensitivity of e.g. a 500 MHz system therefore becomes comparable to a 900 MHz albeit at a small fraction of its price (&amp;lt; 10%). Both spectrometer systems are part of the Departmental NMR facility that operates as a collaborative environment for the structural biology groups of the Departments of Biochemistry and Chemistry. Our proposed program of work contains a large amount of competitive projects that can only be adequately addressed in a high sensitivity NMR environment. The dramatically increased sensitivity will benefit the various structural studies of chromatin proteins, integral membrane proteins, proteins involved in DNA damage response and genomic instability syndromes, protein interactions involved in cell motility, invasion and metastasis, the study of protein folding and misfolding and disease related aggregation processes such as amyloid formation, modular synthetic enzyme systems and many more. The choice of an 800 MHz cryoprobe aims at achieving the best sensitivity on our highest resolution machine. This magnetic field strength provides for us the biggest TROSY improvements so crucial for high molecular weight work and further gives by far the best quality spectra from which we can obtain distance information and derive intermolecular structure data on complexes. All structural projects will benefit from the vastly enhanced performance. The 500 MHz cryoprobe will be used as a high sensitivity tool for triple-resonance experiments and mapping studies.</gtr:technicalSummary><gtr:fund><gtr:end>2008-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2007-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>242086</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Biomolecular NMR studies are frequently constrained by the limited sensitivity of the technique. However, a dramatic 3-fold improvement in NMR sensitivity introduced by cryoprobe technology facilitated through this grant has allowed the users of our Departmental Facility to engage in a range of challenging projects, which would not have been feasible without this new in-house equipment. It has permitted us to remain competitive at an international level both over the grant period and well beyond. Here are some of the findings ordered by research themes:



HMG-box proteins:

Through NMR structural studies we showed that the chromatin destabilizing regulator of gene expression HMGB1 and the linker histone H1, a promotor of stable chromatin interact via their unstructured tail regions, revealing the likely mechanism for switching between stabilised and destabilised chromatin states. We established that this same, highly acidic tail has a regulatory role and is responsible for inhibition of HMGB1 binding to DNA or chromatin through interaction with the HMGB1 DNA-binding region. This furthered also our understanding of how HMGB1 enacts its chaperone role in the binding of certain transcription factors (e.g. the tumor suppressor p53) to their cognate DNA.



7-helical transmembrane proteins:

Membrane proteins are difficult to work with and seven-helical transmembrane proteins in particular. Representing a crucial group of signaling proteins only little structural information on them is available. Using a microbial variant we showed that it is possible to solve structures of such proteins by NMR spectroscopy, to study dynamical aspects and to look at protein-protein interactions. This work was inconceivable without access to an in-house Cryoprobe. 



Voltage-gated sodium channels:

The electrical excitability in neurons depends on the activity of gated sodium channels. The influence of b3-subunit on the gating behaviour of membrane bound NaV1.3 was investigated. Using NMR we reported the first structural analysis of the intracellular domain of any NaV b-subunit and showed involvement of a short helix followed by a disordered region to be involved in fast inactivation. 



Protein folding and misfolding:

The hereditary form of systemic amyloidosis is related to partial unfolding of human Lysozyme. Using NMR local cooperativity was observed during the unfolding process that converts lysozyme into amyloid fibrils. The region that unfolded first correlates with the region that starts fibril formation providing a coherent picture of the initial events underlying amyloid formation.



Structural study of the Virulence factor of sleeping sickness:

The cell surface of African trypanosomes is covered by the glycoprotein, VSG. The structure of the C-terminal di-domain of VSG was determined, and showed evidence for structural conservation in that VSG domain. This allowed building the first structure-based model of a phospholipid anchored protein, which seems to suggest that the lipid glycan may be an integral structural part of these anchored proteins. 



Small GTPases:

Several structures of small GTPases and their complexes with effector proteins were solved such as RalB in its active form and in complex with its effector protein RLIP76. The significance of the polybasic C-terminal region of Rac1 for effector interaction was established and the structure of BART an effector protein of Arl2 was established, showing a novel GTPase binding motif.</gtr:description><gtr:exploitationPathways>Pharmaceutical research and small company bioscience businesses involved in drug development, lead finding and fragment screening directly benefit from our structure based research output into the elucidation of molecular mechanisms. Primarily our studies gather scientific data on protein structure, dynamics and binding to other proteins, DNA and small ligands. The knowledge is used to further mechanistic insight into the diverse molecular regulatory mechanisms of the cell. A wide range of medically relevant themes are addressed including chromatin regulation, membrane protein signaling, amyloid formation, small GTPase signaling and sleeping sickness infection. 



Using NMR we are addressing particular problems, which are difficult to pursue by X-ray crystallography (i.e. a main structural tool) but where atomic resolution information is necessary or where the results of NMR studies are highly complementary. Our research is into generating quality, world-leading research results to enhance the knowledge of biochemistry at the level of molecular processes. Our work furthers academic understanding and is relevant for the advancement of international science. We participate intensely in the academic exchange of information through publication and dissemination of our results.



The approaches employed to do our studies have been made available in the literature and applicable by other research environments. All data generated has been deposited in databases or is readily available upon request.



While academic research, pharmaceutical and small bioscience companies are the ones immediately benefitting from the potential of our fundamental studies, the long term effects via development of drugs and a better understanding of cell signaling at a molecular level will reach much further: they will be the fight of disease and an improvement of health of the general public.</gtr:exploitationPathways><gtr:id>5ADF00DB-FFFF-474B-A33C-1A48158F586C</gtr:id><gtr:outcomeId>r-7581484054.75680277725e04</gtr:outcomeId><gtr:sectors><gtr:sector>Communities and Social Services/Policy,Healthcare,Pharmaceuticals and Medical Biotechnology,Other</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Development of data processing methodology to accelerate NMR spectroscopy.</gtr:description><gtr:id>8F9C1FDA-5BF9-4A18-AFFB-BA1AF52B419C</gtr:id><gtr:impact>The developed methodology enables the study of more complex biological studies using NMR spectroscopy.</gtr:impact><gtr:outcomeId>56d9615dc2ce06.58711720</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Compressed Sensing data reconstruction methodology</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>97646453-7461-4443-A2C3-124A42C96575</gtr:id><gtr:title>NMR analysis of the structure, dynamics, and unique oligomerization properties of the chemokine CCL27.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07a18293e1057187df82d819d8f3d14f"><gtr:id>07a18293e1057187df82d819d8f3d14f</gtr:id><gtr:otherNames>Jansma AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_5435abb5abbc5dfc9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65A31147-8056-46D6-975F-891735F01786</gtr:id><gtr:title>Tail-mediated collapse of HMGB1 is dynamic and occurs via differential binding of the acidic tail to the A and B domains.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/202118e4ac27fad6434c4a6475564f9c"><gtr:id>202118e4ac27fad6434c4a6475564f9c</gtr:id><gtr:otherNames>Stott K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_5435abc5abc30ae42</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0BBD35B-8BB4-479B-BC5C-2707426C5383</gtr:id><gtr:title>The interaction of HMGB1 and linker histones occurs through their acidic and basic tails.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7ca0b82f30661f02e043666f9fa9212"><gtr:id>a7ca0b82f30661f02e043666f9fa9212</gtr:id><gtr:otherNames>Cato L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_5435abc5abc4f0f8c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF0AB363-1AC1-472A-A1CC-DDB60B2C1FBE</gtr:id><gtr:title>1H, 13C and 15N resonance assignments for the small G protein RalB in its active conformation.</gtr:title><gtr:parentPublicationTitle>Biomolecular NMR assignments</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8545b8dfc93ad973cfd8f774729b9a3"><gtr:id>e8545b8dfc93ad973cfd8f774729b9a3</gtr:id><gtr:otherNames>Prasannan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1874-270X</gtr:issn><gtr:outcomeId>pm_5435abb5abb8ee480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8518D69D-0CAA-42FF-BE48-E6FC8734B8F4</gtr:id><gtr:title>Insights into protein-protein and enzyme-substrate interactions in modular polyketide synthases.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ed77a805c982c8d4a956eb45977dcb0"><gtr:id>2ed77a805c982c8d4a956eb45977dcb0</gtr:id><gtr:otherNames>Tran L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>pm_5435abb5abb9a27bd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>198391E2-5B6F-4F26-A8E1-C31C5D05712E</gtr:id><gtr:title>The structure of binder of Arl2 (BART) reveals a novel G protein binding domain: implications for function.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38e4c26417d4519e3dae87121d38b3a0"><gtr:id>38e4c26417d4519e3dae87121d38b3a0</gtr:id><gtr:otherNames>Bailey LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_5435abc5abc78e5b1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4A6BB46-8F31-45C0-AF8C-F19651534A3E</gtr:id><gtr:title>Structure of a glycosylphosphatidylinositol-anchored domain from a trypanosome variant surface glycoprotein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37eda1dea6028df78a242bddaaa180d6"><gtr:id>37eda1dea6028df78a242bddaaa180d6</gtr:id><gtr:otherNames>Jones NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_5435abc5abc2235a9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7189A0B7-901D-446E-AB69-88231D851CD4</gtr:id><gtr:title>Solution NMR studies of polytopic a-helical membrane proteins.</gtr:title><gtr:parentPublicationTitle>Current opinion in structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1eb78344df83f236589b31f138edddaa"><gtr:id>1eb78344df83f236589b31f138edddaa</gtr:id><gtr:otherNames>Nietlispach D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-440X</gtr:issn><gtr:outcomeId>doi_55f94b94ba7c8cbe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96BA5C3E-2B32-4500-93CD-1C6DD221F8A0</gtr:id><gtr:title>Probing the interactions of carboxy-atractyloside and atractyloside with the yeast mitochondrial ADP/ATP carrier.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b22e3d3b2ebd3fef4804dd456b89c5f5"><gtr:id>b22e3d3b2ebd3fef4804dd456b89c5f5</gtr:id><gtr:otherNames>Kedrov A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_5435abb5abbe5bcb6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>411B567C-9F12-4E03-94B9-695DCA18835A</gtr:id><gtr:title>Solution structure and dynamics of the small GTPase RalB in its active conformation: significance for effector protein binding.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c75162adcd6ab92f507c2b9046ddcf"><gtr:id>08c75162adcd6ab92f507c2b9046ddcf</gtr:id><gtr:otherNames>Fenwick RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_5435abc5abc0008ff</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B207F08-F6BB-42F6-ABAF-762F97D015BC</gtr:id><gtr:title>An RNA degradosome assembly in Caulobacter crescentus.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f622b4fd06bb3932400ab9791656507e"><gtr:id>f622b4fd06bb3932400ab9791656507e</gtr:id><gtr:otherNames>Hardwick SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_5435abb5abb4e4bc0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10C00FB6-CDA8-44DE-AA35-A1AE5AFE7ADD</gtr:id><gtr:title>1H, 13C and 15N resonance assignments for Binder of Arl2, BART.</gtr:title><gtr:parentPublicationTitle>Biomolecular NMR assignments</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38e4c26417d4519e3dae87121d38b3a0"><gtr:id>38e4c26417d4519e3dae87121d38b3a0</gtr:id><gtr:otherNames>Bailey LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1874-270X</gtr:issn><gtr:outcomeId>pm_5435abb5abb6ee5d9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7C9D453-ED04-4BDB-B421-6CE0FA9314F9</gtr:id><gtr:title>Structure determination of the seven-helix transmembrane receptor sensory rhodopsin II by solution NMR spectroscopy.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d909fa33edd857c58da3962a745a170f"><gtr:id>d909fa33edd857c58da3962a745a170f</gtr:id><gtr:otherNames>Gautier A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_5435abc5abc16bbc3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71A4632D-B51C-493F-ABB3-F8D5E48E0BA0</gtr:id><gtr:title>The RalB-RLIP76 complex reveals a novel mode of ral-effector interaction.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c75162adcd6ab92f507c2b9046ddcf"><gtr:id>08c75162adcd6ab92f507c2b9046ddcf</gtr:id><gtr:otherNames>Fenwick RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_5435abc5abc632fc4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>141BA7AB-F233-480A-8643-8F673A56840F</gtr:id><gtr:title>NMR protein structure determination in living E. coli cells using nonlinear sampling.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a545103fd5bef3b8ba1a6f8d2e3872b"><gtr:id>1a545103fd5bef3b8ba1a6f8d2e3872b</gtr:id><gtr:otherNames>Ikeya T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>pm_5435abb5abbdc17db</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F85FCDD-E93A-46C8-8D41-18E127EBA604</gtr:id><gtr:title>The sodium channel {beta}3-subunit induces multiphasic gating in NaV1.3 and affects fast inactivation via distinct intracellular regions.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af4aa643e3dbaad74c92d801b07ab35c"><gtr:id>af4aa643e3dbaad74c92d801b07ab35c</gtr:id><gtr:otherNames>Cusdin FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_5435abc5abc6e6c9e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC485814-F684-48B2-B760-F2F2AD9261BA</gtr:id><gtr:title>The Rac1 polybasic region is required for interaction with its effector PRK1.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0f6abab1d5e9e2bc886810024a97bb8"><gtr:id>c0f6abab1d5e9e2bc886810024a97bb8</gtr:id><gtr:otherNames>Modha R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_5435abc5abc594a1c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>004A9690-46D0-4283-8349-D9894BD3C8AE</gtr:id><gtr:title>Solution NMR studies of integral polytopic a-helical membrane proteins: the structure determination of the seven-helix transmembrane receptor sensory rhodopsin II, pSRII.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d909fa33edd857c58da3962a745a170f"><gtr:id>d909fa33edd857c58da3962a745a170f</gtr:id><gtr:otherNames>Gautier A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-62703-022-9</gtr:isbn><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>545b7bb9b0cd66.15463072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC007AB9-A5E5-46CC-A3DE-1F9572AEAE5F</gtr:id><gtr:title>Multienzyme docking in hybrid megasynthetases.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/159f2abb9b7b5c9d7016d803ba6c5c4f"><gtr:id>159f2abb9b7b5c9d7016d803ba6c5c4f</gtr:id><gtr:otherNames>Richter CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>pm_5435abb5abbba03c5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C609D253-BA58-451A-AEB0-5724DD11964E</gtr:id><gtr:title>The effect of purity upon the triple-helical stability of collagenous peptides.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2bf6ecdd71b9c2a69085ff563c22d5d"><gtr:id>b2bf6ecdd71b9c2a69085ff563c22d5d</gtr:id><gtr:otherNames>Slatter DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>pm_5435abc5abc43c340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1A7A762-D15C-43F7-A01A-9BFA4C0ABEDF</gtr:id><gtr:title>1H, 13C and 15N resonance assignments of the GTPase-activating (GAP) and Ral binding domains (GBD) of RLIP76 (RalBP1).</gtr:title><gtr:parentPublicationTitle>Biomolecular NMR assignments</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfbf33388cb7a46760c7ac07f0e2431e"><gtr:id>cfbf33388cb7a46760c7ac07f0e2431e</gtr:id><gtr:otherNames>Rajasekar KV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1874-270X</gtr:issn><gtr:outcomeId>545b7bb9de47e5.78647199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5116F422-88F4-430B-BF62-49C7C6790108</gtr:id><gtr:title>Solution-state NMR spectroscopy of a seven-helix transmembrane protein receptor: backbone assignment, secondary structure, and dynamics.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d909fa33edd857c58da3962a745a170f"><gtr:id>d909fa33edd857c58da3962a745a170f</gtr:id><gtr:otherNames>Gautier A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>58aa045906c244.48186866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D57E029-0BCC-4823-8EAF-E2EDBCC7C53E</gtr:id><gtr:title>1H, 13C and 15N resonance assignments for the active conformation of the small G protein RalB in complex with its effector RLIP76.</gtr:title><gtr:parentPublicationTitle>Biomolecular NMR assignments</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c75162adcd6ab92f507c2b9046ddcf"><gtr:id>08c75162adcd6ab92f507c2b9046ddcf</gtr:id><gtr:otherNames>Fenwick RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1874-270X</gtr:issn><gtr:outcomeId>pm_5435abb5abb8531a7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CADF9BB-EA4F-4AC7-B6D4-C86523882F7A</gtr:id><gtr:title>A surface loop directs conformational switching of a lipoyl domain between a folded and a novel misfolded structure.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43893935346c0886085be54862f1e46b"><gtr:id>43893935346c0886085be54862f1e46b</gtr:id><gtr:otherNames>Stott KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_5435abb5abb42f577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6E52375-0ACA-49DC-9985-12933CCA96A4</gtr:id><gtr:title>Sticky swinging arm dynamics: studies of an acyl carrier protein domain from the mycolactone polyketide synthase.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93fdb9efdbcb15b809e33dc57053b885"><gtr:id>93fdb9efdbcb15b809e33dc57053b885</gtr:id><gtr:otherNames>Vance S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5a60d804d00818.20781522</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EC76E5C-F9DD-46A9-8A24-3CF3A2FFDDAB</gtr:id><gtr:title>Resonance assignments for the RLIP76 Ral binding domain in its free form and in complex with the small G protein RalB.</gtr:title><gtr:parentPublicationTitle>Biomolecular NMR assignments</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c75162adcd6ab92f507c2b9046ddcf"><gtr:id>08c75162adcd6ab92f507c2b9046ddcf</gtr:id><gtr:otherNames>Fenwick RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1874-270X</gtr:issn><gtr:outcomeId>pm_5435abb5abbf2a121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBC535E0-1258-4EBD-948B-12162D367519</gtr:id><gtr:title>Local cooperativity in an amyloidogenic state of human lysozyme observed at atomic resolution.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f4b579ece82efcdde70786df140f297"><gtr:id>1f4b579ece82efcdde70786df140f297</gtr:id><gtr:otherNames>Dhulesia A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>pm_5435abb5abba6d8eb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD77858E-AB1C-4CF8-8BD7-9895C439D355</gtr:id><gtr:title>NMR assignment of human chemerin, a novel chemoattractant.</gtr:title><gtr:parentPublicationTitle>Biomolecular NMR assignments</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2a08b4ca3158268cbd061d6c064ccf6"><gtr:id>d2a08b4ca3158268cbd061d6c064ccf6</gtr:id><gtr:otherNames>Allen SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1874-270X</gtr:issn><gtr:outcomeId>pm_5435abb5abbd120c3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5B8DCE5-C41F-432F-A5F9-94D2E31F90DF</gtr:id><gtr:title>A critical role in structure-specific DNA binding for the acetylatable lysine residues in HMGB1.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8acfedd4763a384175bc1eb335a940dd"><gtr:id>8acfedd4763a384175bc1eb335a940dd</gtr:id><gtr:otherNames>Assenberg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_5435abb5abb3940ea</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10C356A7-86BC-45B4-B1DA-9E7052C536D4</gtr:id><gtr:title>Mapping intramolecular interactions between domains in HMGB1 using a tail-truncation approach.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e013fcaaaddf1698b63f135fa6b7701"><gtr:id>3e013fcaaaddf1698b63f135fa6b7701</gtr:id><gtr:otherNames>Watson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_5435abb5abbb11ae5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27B2B455-2075-462C-94A8-EA0F669071A6</gtr:id><gtr:title>The structure of the RLIP76 RhoGAP-Ral binding domain dyad: fixed position of the domains leads to dual engagement of small G proteins at the membrane.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfbf33388cb7a46760c7ac07f0e2431e"><gtr:id>cfbf33388cb7a46760c7ac07f0e2431e</gtr:id><gtr:otherNames>Rajasekar KV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>545b7bb8c6e3f0.96687979</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/E013228/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>